Tris Pharma Receives U.S. FDA Approval for Once-Daily ONYDA XR (clonidine hydrochloride) Extended-Release Oral Suspension, the First-and-Only Liquid Non-Stimulant ADHD Medication
ONYDA XR is indicated for the treatment of ADHD as [...]
FDA Grants AI-Powered Notal Vision Home OCT “SCANLY” De Novo Marketing Authorization
“We are very excited to receive FDA authorization to market [...]
Inspira™ Announces 95% Accuracy Results for HYLA ™ Blood Sensor, Planning FDA Submission for Clearance in 2024
The development of the first HYLA variant, key to this [...]
CymaBay Submits New Drug Application to FDA for Seladelpar for the Treatment of Primary Biliary Cholangitis
Seladelpar has been granted Breakthrough Therapy Designation by the FDA [...]
Ad Astra Diagnostics Receives 510(k) Clearance of QScout™ Hematology Analyzer
QScout is the first hematology platform designed for simple, fast [...]
BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device
The BD MiniDraw Capillary Blood Collection System is less invasive than [...]
Brainomix Targets US Expansion with the Launch of its Cutting-Edge Stroke AI Platform Following Series of FDA Clearances
The recent FDA clearances included Brainomix 360 e-CTP and Brainomix [...]
Telesair Receives FDA Clearance for Bonhawa High Flow Oxygen Therapy System
“The best in class Bonhawa system greatly improves patient care [...]
FDA Grants Fast Track Designation to 9MW3011
9MW3011 has been approved to clinical study by NMPA and [...]
MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil
“We are pleased to gain the QIDP and Fast Track [...]